✦ LIBER ✦

Preclinical safety and immunogenicity evaluation of a nonavalent PorA native outer membrane vesicle vaccine against serogroup B meningococcal disease

✍ Scribed by Kaaijk, Patricia; van Straaten, Ineke; van de Waterbeemd, Bas; Boot, Elmieke P.J.; Levels, Lonneke M.A.R.; van Dijken, Harry H.; van den Dobbelsteen, Germie P.J.M.

Book ID: 120541025
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 429 KB
Volume: 31
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2012.12.031

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and immunogenicity testing of an

Safety and immunogenicity testing of an intranasal group B meningococcal native outer membrane vesicle vaccine in healthy volunteers

✍ Joseph J. Drabick; Brenda L. Brandt; Elizabeth E. Moran; Nancy B. Saunders; Davi 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 283 KB

Design and evaluation in mice of a broad

Design and evaluation in mice of a broadly protective meningococcal group B native outer membrane vesicle vaccine

✍ Wendell D. Zollinger; Mikhail A. Donets; Deborah H. Schmiel; Valerian B. Pinto; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 415 KB

Immunogenicity and bactericidal activity

Immunogenicity and bactericidal activity in mice of an outer membrane protein vesicle vaccine against Neisseria meningitidis serogroup A disease

✍ Gunnstein Norheim; E Arne Høiby; Dominique A Caugant; Ellen Namork; Torill Tange 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 207 KB

A phase 1 study of a meningococcal nativ

A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expression

✍ P.B. Keiser; S. Biggs-Cicatelli; E.E. Moran; D.H. Schmiel; V.B. Pinto; R.E. Burd 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 547 KB